Trading Signals: CEMI Stock Price Prediction and Forecast (Wed. Nov. 26, 2003 - Wed. Jul. 21, 2021)(Chembio Diagnostics Inc)
| CEMI latest price $6.3500 (2.09%) ($6.2200 - $6.4800) on Tue. Jun. 11, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.79% (three month average) | RSI | 28 | Latest Price | $6.3500(2.09%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CEMI declines -1.1% a day on average for past five trading days. | Weekly Trend | CEMI declines -4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support CEMI advance at 0% a week (0% probability) ARKG(11%) VIXM(8%) XBI(8%) IGOV(7%) SHY(7%) | Factors Impacting CEMI price | CEMI will decline at least -1.395% in a week (0% probabilities). UNG(-11%) IFRA(-7%) XLP(-5%) VXX(-5%) XOP(-4%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.395% (StdDev 2.79%) | Hourly BBV | 0 () | Intraday Trend | 1.3% | | | |
|
1 - 5 Day Possible Target | $-7.61(-219.84%) | Resistance Level | $6.99 | 5 Day Moving Average | $6.57(-3.35%) | 10 Day Moving Average | $6.59(-3.64%) | 20 Day Moving Average | $6.99(-9.16%) | To recent high | -19.1% | To recent low | 19.4% | Market Cap | $128m | | | | Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. The firm expanding its product portfolio based upon the proprietary Dual Path Platform, which uses a small drop of blood from the fingertip to provide cost-effective diagnostic results in approximately 15 minutes. Its products include human and veterinary diagnostics. The company was founded in 1985 and is headquartered in Hauppauge, NY. |